Great and inspiring #microbiome meeting with celebrities of the field. Thanks to Andre, Vanessa, Philip and Anita for the organisation and invitation.

Nice talk by @JonelTrebicka presenting the results of @TransHep_GUF from the last two years on portal hypertension and liver fibrosis.

Doctors and scientists need to speak the same language, say two new PhD4MD fellows @idibaps @LiverHope_h2020. #EndHep #HealthForAll 🇪🇺 @Marko_Korenjak @EU_Health @V_Andriukaitis @WHO_Europe @ECDC_HIVAIDS @ECDC_EU @EMCDDA @Moedas https://t.co/g6xoyV9umJ

Prof. Elsa Sola presented Design and endpoints of clinical trials in decompensated cirrhosis. @LiverHope_h2020 #EndHep #HealthForAll 🇪🇺 @Marko_Korenjak @EU_Health @V_Andriukaitis @WHO_Europe @ECDC_HIVAIDS @ECDC_EU @EMCDDA @Moedas

Marta Carol from @idibaps, Spain presented improvements we plan in nursing care with patients with https://t.co/yIpRy7cSan. @LiverHope_h2020 #EndHep #HealthForAll 🇪🇺 @Marko_Korenjak @EU_Health @WHO_Europe @ECDC_HIVAIDS @ECDC_EU @EMCDDA

@LiverHope_h2020 project will intruduce the first document about nurses care of cirrotic patients in the world, said Prof. Pere Gines @LiverHope_h2020 #EndHep #HealthForAll 🇪🇺 @Marko_Korenjak @EU_Health @V_Andriukaitis @WHO_Europe @ECDC_HIVAIDS @ECDC_EU @EMCDDA @Moedas @rixwolff

Looking forward to start the second annual MEETING @LiverHope_h2020 in Barcelona. Prof. Pere Gines prepares the final points before the start of the meeting #EndHep in 🇪🇺 #HealthForAll @Marko_Korenjak @asscatinforma

Prof. Pere Gines: @LiverHope_h2020 project will have and already has several positive points that needs to be addressed. Stigma, lack of knowledge... #EndHep #HealthForAll 🇪🇺 @Marko_Korenjak @EU_Health @V_Andriukaitis @WHO_Europe @ECDC_HIVAIDS @ECDC_EU @EMCDDA @Moedas @rixwolff

Prof. Pere Gines opens the @LiverHope_h2020 meeting in Barcelona. Excellent start new hope with new therapy for patients with decompensated #cirrosis #EndHep #HealthForAll in 🇪🇺 @Marko_Korenjak @ASSCATINFORMA @EU_Health @V_Andriukaitis @WHO_Europe @Moedas @ECDC_HIVAIDS @ECDC_EU

On 26th April, Aleksander Krag received the Order of Odd Fellow's Research prize for an outstanding contribution to Danish Research - there was a ceremony with many nobelties including representatives from the royal family (Her Royal Highness Princess Benedikte). Congrats!

Leversyge patienter skal findes i tide! Det kræver bedre samarbejde mellem almen praktiserende læge, sygehus og #leverforskning og så skal vi benytte alle de nye muligheder som #AI byder på. https://t.co/ATUq8Qyea5 @SUND_SDU @SyddanskUniv

Our biggest fans this week: @MicrobPredict, @JonelTrebicka, @TransHep_GUF. Thank you! via https://t.co/k4koOXzYlM

Mechanosensor of angiocrine signaling in the liver discovered. Fundamental insights into vascular control mechanisms of organ function. Great work Ecki!

#Sarcopenia is a predictor of #ACLF and mortality in patients with #cirrhosis after TIPS. Read more about it in our recent collaborative publication published in #ClinicalAndTranslationalGastroenterology. https://t.co/vEmQv7vbBB #openaccess @UniBonn @goetheuni @SapienzaRoma

Interview for Romanian health TV. Speaking about next steps in hepatitis elimination and taking the stigma of cured patients.@Marko_Korenjak

ELPA is activly involved in @VHPBorg Advisory and a multitopic Technical meetings 24-26 of April in Vilnius, Lithuania

The first meeting dedicated to validation of biomarkers and #biosensor development (WP5) was held at ICN2/Barcelona on 26/03. The aim was to initiate the collaboration of ICN2 and CEA regarding the development of point of care tests. @icn2nano @ArbenMerkoci #cirrhosis #microbiome

The EU-funded @MicrobPredict is launched! Microbiome experts like EMBL's @Borklab join forces with technology leaders, clinical specialists and patient organisations to understand how the human microbiome contributes to the development of liver disease: https://t.co/zYVC0MAAFG